Expression of signal transduction proteins during the differentiation of primary human erythroblasts

Journal of Cellular Physiology

Volumn 202, Issue 3, 2005, Pages 831-838

  Di Giacomo, Viviana ^a   Matteucci, Alessandro ^b   Stellacci, Emilia ^a   Battistini, Angela ^a   Di Baldassarre, Angela ^c   Capitani, Silvano ^d   Alfani, Elena ^a   Migliaccio, Anna Rita ^a   Cocco, Lucio ^b   Migliaccio, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; ERYTHROPOIETIN; INTERFERON REGULATORY FACTOR 1; PROTEIN BCL XL; STAT PROTEIN;

ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CHROMATIN; ERYTHROBLAST; ERYTHROID CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, CD; BCL-X PROTEIN; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL SHAPE; CELLS, CULTURED; DNA-BINDING PROTEINS; ERYTHROBLASTS; ERYTHROPOIESIS; HUMANS; INTERFERON REGULATORY FACTOR-1; ISOENZYMES; PHOSPHOLIPASE C; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 19944431248     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20179     Document Type: Article

References (70)

1. Adamson JW. 1968. The erythropoietin-hematocrit relationship in normal and polycythemic man: Implications of marrow regulation. Blood 32(4):597-609.
2. Bouscary D, Pene F, Claessens YE, Muller O, Chretien S, Fontenay-Roupie M, Gisselbrecht S, Mayeux P, Lacombe C. 2003. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Blood 101(9):3436-3443.
3. Cenciarelli C, De Santa F, Puri PL, Mattei E, Ricci L, Bucci F, Felsani A, Caruso M. 1999. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation. Mol Cell Biol 19(7):5203-5217.
4. Coccia EM, Stellacci E, Valtieri M, Masella B, Feccia T, Marziali G, Hiscott J, Testa U, Peschle C, Battistini A. 2001. Ectopic expression of interferon regulatory factor-1 potentiates granulocytic differentiation. Biochem J 360(2):285-294.
5. Cocco L, Martelli AM, Gilmour RS, Rhee SG, Manzoli FA. 2001. Nuclear phospholipase C and signaling. Biochim Biophys Acta 1530(1):1-14.
6. Cotner T, Gupta AD, Papayannopoulou T, Stamatoyannopoulos G. 1989. Characterization of a novel form of transferrin receptor preferentially expressed on normal erythroid progenitors and precursors. Blood 73(1):214-221.
7. Damen JE, Liu L, Cutler RL, Krystal G. 1993. Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood 82(8):2296-2303.
8. Damen JE, Wakao H, Miyajima A, Krosl J, Humphries RK, Cutler RL, Krystal G. 1995. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. Embo J 14(22):5557-5568.
9. D'Andrea AD, Zon LI. 1990. Erythropoietin receptor. Subunit structure and activation. J Clin Invest 86(3):681-687.
10. D'Andrea AD, Lodish HF, Wong GG. 1989. Expression cloning of the murine erythropoietin receptor. Cell 57(2):277-285.
11. Darnell JE, Jr. 1997, STATs and gene regulation. Science 277(5332):1630-1635.
12. Dawson DW, Pearce SF, Zhong R, Silverstein RL, Frazier WA, Bouck NP. 1997. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol 138(3):707-717.
13. Decker T, Kovarik P, Meinke A. 1997. GAS elements: A few nucleotides with a major impact on cvtokine-induced gene expression. J Interferon Cytokine Res 17(3):121-134.
14. Divecha N, Irvine RF. 1995. Phospholipid signaling. Cell 80(2):269-278.
15. Faenza I, Matteucci A, Manzoli L, Billi AM, Aluigi M, Peruzzi D, Vitale M, Castorina S, Suh PG, Cocco L. 2000. A role for nuclear phospholipase Cbeta 1 in cell cycle control. J Biol Chem 275(39):30520-30524.
16. Faenza I, Matteucci A, Bavelloni A, Marmiroli S, Martelli AM, Gilmour RS, Suh PG, Manzoli L, Cocco L. 2002. Nuclear PLCbeta(1) acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells. Biochim Biophys Acta 1589(3):305-310.
17. Faenza I, Bavelloni A, Fiume R, Lattanzi G, Maraldi NM, Gilmour RS, Martelli AM, Suh PG, Billi AM, Cocco L. 2003. Up-regulation of nuclear PLCbeta1 in myogenic differentiation. J Cell Physiol 195(3):446-452.
18. Fibach E, Manor D, Oppenheim A, Rachmilewitz EA. 1989. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 73(1):100-103.
19. Fujio Y, Kunisada K, Hirota H, Yamauchi-Takihara K, Kishimoto T. 1997. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J Clin Invest 99(12):2898-2905.
20. Goldwasser E. 1984. Erythropoietin and its mode of action. Blood Cells 10(2-3):147-162.
21. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. 1992. Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction, and transfusion medicine. Blood 80(5):1105-1115.
22. Gregoli PA, Bondurant MC. 1997. The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin. Blood 90(2):630-640.
23. Gregory CJ, Eaves AC. 1977. Human marrow cells capable of erythropoietic differentiation in vitro: Definition of three erythroid colony responses. Blood 49(6):855-864.
24. Haseyama Y, Sawada K, Oda A, Koizumi K, Takano H, Tarumi T, Nishio M, Handa M, Ikeda Y, Koike T. 1999. Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. Blood 94(5):1568-1577.
25. Iacopetta BJ, Morgan EH, Yeoh GC. 1982. Transferrin receptors and iron uptake during erythroid cell development. Biochim Biophys Acta 687(2):204-210.
26. Ihle JN. 1996. STATs: Signal transducers and activators of transcription. Cell 84(3):331-334.
27. Irvine RF. 2003. Nuclear lipid signalling. Nat Rev Mol Cell Biol 4(5):349-360.
28. Kawabata H, Yang R, Hirama T, Vuong PT, Kawano S, Gombart AF, Koeffler HP, 1999. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 274(30):20826-20832.
29. Kieslinger M, Woldman I, Moriggl R, Hofmann J, Marine JC, Ihle J, beug H, Decker T. 2000. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes and Develop 14:232-244.
30. Kina T, Ikuta K, Takayama E, Wada K, Majumdar AS, Weissman IL, Katsura Y. 2000. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br J Haematol 109(2):280-287.
31. Kirito K, Uchida M, Yamada M, Miura Y, Komatsu N. 1997. A distinct function of STAT proteins in erythropoietin signal transduction. J Biol Chem 272(26):16507-16513.
32. Kirito K, Nakajima K, Watanabe T, Uchida M, Tanaka M, Ozawa K, Komatsu N. 2002. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation. Blood 99(1):102-110.
33. Klingmuller U, Bergelson S, Hsiao JG, Lodish HF. 1996. Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5. Proc Natl Acad Sci USA 93(16):8324-8328.
34. Leevers SJ, Vanhaesebroeck B, Waterfield MD. 1999. Signalling through phosphoinositide 3-kinases: The lipids take centre stage. Curr Opin Cell Biol 11(2):219-225.
35. Liboi E, Carroll M, D'Andrea AD, Mathey-Prevot B. 1993. Erythropoietin receptor signals both proliferation and erythroid-specific differentiation. Proc Natl Acad Sci USA 90(23):11351-11355.
36. Martelli AM, Billi AM, Gilmour RS, Neri LM, Manzoli L, Ognibene A, Cocco L. 1994. Phosphoinositide signaling in nuclei of Friend cells: Phospholipase C beta down-regulation is related to cell differentiation. Cancer Res 54(10):2536-2540.
37. Martelli AM, Manzoli L, Cocco L. 2004. Nuclear inositides: Facts and perspectives. Pharmacol Ther 101(1):47-64.
38. Matsuno K, Diaz-Ricart M, Montgomery RR, Aster RH, Jamieson GA, Tandon NN. 1996. Inhibition of platelet adhesion to collagen by monoclonal anti-CD36 antibodies. Br J Haematol 92(4):960-967.
39. Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kundig TM, Amakawa R, Kishihara K, Wakeham A, Potter J, Furlonger CL, Norendran A, Suzuki H, Ohashi PS, Paige CL, Taniguchi T, Mak TW. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75(1):83-97.
40. Matteucci A, Faenza I, Gilmour RS, Manzoli L, Billi AM, Peruzzi D, Bavelloni A, Rhee SG, Cocco L. 1998. Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells. Cancer Res 58(22):5057-5060.
41. Mayeux P, Dusanter-Fourt I, Muller O, Mauduit P, Sabbah M, Druker B, Vainchenker W, Fischer S, Lacombe C, Gisselbrecht S. 1993. Erythropoietin induces the association of phosphatidylinositol 3′-kinase with a tyrosine-phosphorylated protein complex containing the erythropoietin receptor. Eur J Biochem 216(3):821-828.
42. Migliaccio G, Di Pietro R, di Giacomo V, Di Baldassarre A, Migliaccio AR, Maccioni L, Galanello R, Papayannopoulou T. 2002. In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis 28(2):169-180.
43. Miura O, Nakamura N, Ihle JN, Aoki N. 1994. Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. J Biol Chem 269(1):614-620.
44. Mui AL, Wakao H, Kinoshita T, Kitamura T, Miyajima A. 1996. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: Role of Stat5 in proliferation. Embo J 15(10):2425-2433.
45. Ohashi T, Masuda M, Ruscetti SK. 1995. Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus. Blood 85(6):1454-1462.
46. Pang Q, Fagerlie S, Christianson TA, Keeble W, Faulkner G, Diaz J, Rathbun RK, Bagby GC. 2000. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors. Mol Cell Biol 20(13):4724-4735.
47. Papayannopoulou T, Migliaccio AR, D'Andrea AD. 2003. Biology of erythropoiesis, erythroid differentiation and maturation. In: Hoffman R, editor. Hematology: Basic principles and practice. 4th ed. NY: Churchill Livingstone.
48. Penta K, Sawyer ST. 1995. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells. J Biol Chem 270(52):31282-31287.
49. Quelle FW, Wang D, Nosaka T, Thierfelder WE, Stravopodis D, Weinstein Y, Ihle JN. 1996. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol Cell Biol 16(4):1622-1631.
50. Ren HY, Komatsu N, Shimizu R, Okada K, Miura Y. 1994. Erythropoietin induces tyrosine phosphorylation and activation of phospholipase C-gamma 1 in a human erythropoietin-dependent cell line. J Biol Chem 269(30):19633-19638.
51. Rhee SG. 2001. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70:281-312.
52. Robinson J, Sieff C, Delia D, Edwards PA, Greaves M. 1981. Expression of cell-surface HLA-DR, HLA-ABC and glycophorin during erythroid differentiation. Nature 289(5793):68-71.
53. Sawyer ST, Krantz SB. 1986. Transferrin receptor number, synthesis, and endocytosis during erythropoietin-induced maturation of Friend virus-infected erythroid cells. J Biol Chem 261(20):9187-9195.
54. Shimada Y, Migliaccio G, Ralph H, Migliaccio AR, Shaw H. 1993. Erythropoietin-specific cell cycle progression in erythroid subclones of the interleukin-3-dependent cell line 32D. Blood 81(4):935-941.
55. Shivdasani RA, Orkin SH. 1996. The transcriptional control of hematopoiesis. Blood 87(10):4025-4039.
56. Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C, Lodish HF. 2001. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 98(12):3261-3273.
57. Tandon NN, Kralisz U, Jamieson GA. 1989. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 264(13):7576-7583.
58. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. 2001. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19:623-655.
59. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN. 1998. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93(5):841-850.
60. Testa U, Stellacci E, Pelosi E, Sestili P, Venditti M, Orsatti R, Fragale A, Petrucci E, Pasquini L, Belardelli F, Gabriele L, Battistini A, 2004. Impaired granulopoiesis in mice devoid of Interferon Regulatory Factor 1. Leukemia, in press.
61. Toba K, Hanawa H, Watanabe K, Fuse I, Masuko M, Miyajima S, Takahashi M, Sakaue M, Abo T, Aizawa Y. 2001. Erythroid involvement in CD36 deficiency. Exp Hematol 29(10):1194-1200.
62. Vanhaesebroeck B, Waterfield MD. 1999. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253(1):239-254.
63. Vannucchi AM, Bianchi L, Cellai C, Paoletti F, Carrai V, Calzolari A, Centurione L, Lorenzini R, Carta C, Alfani E, Sanchez M, Migliaccio G, Migliaccio AR. 2001, Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice). Blood 97(10):3040-3050.
64. Vitale M, Matteucci A, Manzoli L, Rodella L, Mariani AR, Zauli G, Falconi M, Billi AM, Martelli AM, Gilmour RS, Cocco L. 2001. Interleukin 2 activates nuclear phospholipase Cbeta by mitogen-activated protein kinase-dependent phosphorylation in human natural killer cells. Faseb J 15(10):1789-1791.
65. Wickrema A, Uddin S, Sharma A, Chen F, Alsayed Y, Ahmad S, Sawyer ST, Krystal G, Yi T, Nishada K, Hibi M, Hirano T, Platanias LC. 1999. Engagement of Gab1 and Gab2 in erythropoietin signaling. J Biol Chem 274(35):24469-24474.
66. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN. 1993. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74(2):227-236.
67. Wojda U, Leigh KR, Njoroge JM, Jackson KA, Natarajan B, Stitely M, Miller JL. 2003. Fetal hemoglobin modulation during human erythropoiesis: Stem cell factor has "late" effects related to the expression pattern of CD117. Blood 101(2):492-497.
68. Zang H, Sato K, Nakajima H, McKay C, Ney PA, Ihle JN. 2001. The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis. Embo J 20(12):3156-3166.
69. Ziegler BL, Muller R, Valtieri M, Lamping CP, Thomas CA, Gabbianelli M, Giesert C, Buhring HJ, Kanz L, Peschle C. 1999. Unicellular-unilineage erythropoietic cultures: Molecular analysis of regulatory gene expression at sibling cell level. Blood 93(10):3355-3368.
70. Zon LI, Youssoufian H, Mather C, Lodish HF, Orkin SH. 1991. Activation of the erythropoietin receptor promoter by transcription factor GATA-1. Proc Natl Acad Sci USA 88(23):10638-10641.